跳至主要内容
临床试验/DRKS00034193
DRKS00034193招募中Unknown

pper limb training with virtual reality in patients with Parkinson's disease: a randomised controlled trial

CUREosity GmbH0 个研究点目标入组 58 人开始时间: 2024年5月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients diagnosed with Parkinson's disease according to the Parkinson's Disease Society Brain Bank criteria, aged =18 years; male, female or diverse gender; Hoehn and Yahr stage I-IV, with impaired function of one or both upper extremities (evaluated by a neurologist), with adequate cognitive function (Mini Mental State Examination Score =24/30), which are clinically stable and constant dose of dopaminergic therapy received, and with written consent after medical and therapeutic information. Patients will be included in the study if they have an inpatient neurological rehabilitation stay at Clinic for Rehabilitation Münster, Tyrol or at Klinikum Bad Hall & Bad Schallerbach, location Bad Hall during the study period.

排除标准

  • Patients with diagnosed pronounced vertigo associated with possible motion/cyber sickness, other neurological, psychiatric or severe orthopaedic/rheumatological diseases, malignant diseases or any other impaired health condition that could affect the intervention or testing are excluded. Also excluded are patients with recent surgical interventions on the joints or soft tissues of the upper extremities or cervical spine, pronounced arthrosis or inflammatory diseases of the upper extremity as well as untreated visual or hearing disorders and pregnancy according to pregnancy test in women of childbearing age prior to enrolment in the clinical trial. In the event of a change in medication that may influence the results (especially dopaminergic medication), patients may be excluded from the study at the discretion of the investigators. Any change of medication will be documented in the study protocol.
  • At the discretion of the investigator, patients with
  • - a fracture tendency or existing fractures, e.g. severe osteoporosis or osteomalacia, neoplastic, pathological, or traumatic genesis
  • - uncontrollable disturbance of vital functions, e.g. pulmonary and/or cardiovascular diseases (instability, drug, or instrumental support for these functions)
  • - acute exacerbation of Parkinson's disease
  • - intravenous access in the upper extremities with ongoing infusion
  • - shoulder joint (sub)dislocation or unacceptable pain in the shoulder joint
  • - uncontrollable epilepsy and seizures
  • - uncorrectable severe visual impairment that precludes the use of an HMD (head-mounted display) (e.g. complete blindness)
  • - pronounced hypacusis or lack of the necessary aids to compensate for this
  • - uncontrollable vestibular disease
  • - acute migraine attack
  • - lack of adaptability of the VR headset to the head size
  • - insufficient/insufficient strength of the neck muscles to wear the VR headset

研究者

发起方
CUREosity GmbH

相似试验